590006 Stock Overview
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins.
Amrutanjan Health Care Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₹825.70|
|52 Week High||₹1,025.55|
|52 Week Low||₹654.65|
|1 Month Change||-11.61%|
|3 Month Change||2.39%|
|1 Year Change||11.24%|
|3 Year Change||185.31%|
|5 Year Change||139.25%|
|Change since IPO||7,011.97%|
Recent News & Updates
|590006||IN Pharmaceuticals||IN Market|
Return vs Industry: 590006 exceeded the Indian Pharmaceuticals industry which returned -10.4% over the past year.
Return vs Market: 590006 matched the Indian Market which returned 10.6% over the past year.
|590006 Average Weekly Movement||5.3%|
|Pharmaceuticals Industry Average Movement||7.0%|
|Market Average Movement||7.2%|
|10% most volatile stocks in IN Market||10.0%|
|10% least volatile stocks in IN Market||4.8%|
Stable Share Price: 590006 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 590006's weekly volatility (5%) has been stable over the past year.
About the Company
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons and lotions, body pain gels, and joint muscle sprays, as well as diclofenac, a non-steroidal anti-inflammatory drug.
Amrutanjan Health Care Fundamentals Summary
|590006 fundamental statistics|
Is 590006 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|590006 income statement (TTM)|
|Cost of Revenue||₹1.74b|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||21.45|
|Net Profit Margin||15.94%|
How did 590006 perform over the long term?See historical performance and comparison
0.6%Current Dividend Yield
Is Amrutanjan Health Care undervalued compared to its fair value and its price relative to the market?
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 590006 (₹825.7) is trading above our estimate of fair value (₹319.56)
Significantly Below Fair Value: 590006 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 590006 is poor value based on its PE Ratio (38.5x) compared to the Indian Pharmaceuticals industry average (21.4x).
PE vs Market: 590006 is poor value based on its PE Ratio (38.5x) compared to the Indian market (20.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 590006's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 590006 is overvalued based on its PB Ratio (10.1x) compared to the IN Pharmaceuticals industry average (2.6x).
How is Amrutanjan Health Care forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Amrutanjan Health Care has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Amrutanjan Health Care performed over the past 5 years?
Past Performance Score3/6
Past Performance Score 3/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 590006 has high quality earnings.
Growing Profit Margin: 590006's current net profit margins (15.9%) are lower than last year (19.7%).
Past Earnings Growth Analysis
Earnings Trend: 590006's earnings have grown significantly by 34.2% per year over the past 5 years.
Accelerating Growth: 590006's earnings growth over the past year (6.6%) is below its 5-year average (34.2% per year).
Earnings vs Industry: 590006 earnings growth over the past year (6.6%) underperformed the Pharmaceuticals industry 12.5%.
Return on Equity
High ROE: 590006's Return on Equity (26.2%) is considered high.
How is Amrutanjan Health Care's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 590006's short term assets (₹2.5B) exceed its short term liabilities (₹646.3M).
Long Term Liabilities: 590006's short term assets (₹2.5B) exceed its long term liabilities (₹72.6M).
Debt to Equity History and Analysis
Debt Level: 590006 has more cash than its total debt.
Reducing Debt: 590006's debt to equity ratio has reduced from 2% to 0.4% over the past 5 years.
Debt Coverage: 590006's debt is well covered by operating cash flow (4474.5%).
Interest Coverage: 590006 earns more interest than it pays, so coverage of interest payments is not a concern.
What is Amrutanjan Health Care current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 590006's dividend (0.56%) is higher than the bottom 25% of dividend payers in the Indian market (0.35%).
High Dividend: 590006's dividend (0.56%) is low compared to the top 25% of dividend payers in the Indian market (1.58%).
Stability and Growth of Payments
Stable Dividend: 590006's dividend payments have been volatile in the past 10 years.
Growing Dividend: 590006's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (21.4%), 590006's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (36.5%), 590006's dividend payments are well covered by cash flows.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Sambhu Sivalenka (47 yo)
Mr. Sambhu Prasad Sivalenka, B.Tech (USA), M.B.A. (USA) has been the Managing Director of Amrutanjan Health Care Limited and serves as its Chairman since February 13, 2012. He has been Director of Amrutan...
CEO Compensation Analysis
Compensation vs Market: Insufficient data to establish whether Sambhu's total compensation is reasonable compared to companies of similar size in the Indian market.
Compensation vs Earnings: Sambhu's compensation has been consistent with company performance over the past year.
Experienced Board: 590006's board of directors are considered experienced (7.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Amrutanjan Health Care Limited's employee growth, exchange listings and data sources
- Name: Amrutanjan Health Care Limited
- Ticker: 590006
- Exchange: BSE
- Founded: 1893
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Implied Market Cap: ₹24.076b
- Shares outstanding: 29.23m
- Website: https://www.amrutanjan.com
Number of Employees
- Amrutanjan Health Care Limited
- No.103 (Old No.42-45), Luz Church Road
- Tamil Nadu
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/18 00:00|
|End of Day Share Price||2022/05/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.